NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News & Analysis

$56.99
+1.20 (+2.15 %)
(As of 09/16/2019 04:00 PM ET)
Today's Range
$54.77
Now: $56.99
$57.65
50-Day Range
$52.67
MA: $59.40
$65.65
52-Week Range
$40.86
Now: $56.99
$83.44
Volume179,300 shs
Average Volume371,585 shs
Market Capitalization$1.26 billion
P/E Ratio167.62
Dividend YieldN/A
Beta1.67
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems. Read More…

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
CUSIPN/A
Phone866-648-2767

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$204.27 million
Cash Flow$1.2935 per share
Book Value$6.79 per share

Profitability

Net Income$-47,270,000.00

Miscellaneous

Employees952
Market Cap$1.26 billion
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.


Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) posted its quarterly earnings data on Thursday, August, 8th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.06 by $0.29. The business had revenue of $76.26 million for the quarter, compared to analysts' expectations of $70.40 million. Tabula Rasa HealthCare had a positive return on equity of 3.63% and a negative net margin of 7.09%. The business's revenue was up 56.9% on a year-over-year basis. During the same quarter last year, the firm earned $0.20 earnings per share. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Tuesday, November 5th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its third quarter 2019 earnings guidance on Thursday, August, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $74-77 million, compared to the consensus revenue estimate of $75.82 million.

What price target have analysts set for TRHC?

10 Wall Street analysts have issued twelve-month target prices for Tabula Rasa HealthCare's shares. Their predictions range from $58.00 to $100.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $82.2330 in the next twelve months. This suggests a possible upside of 44.3% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating, 8 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

Has Tabula Rasa HealthCare been receiving favorable news coverage?

News stories about TRHC stock have trended somewhat positive recently, InfoTrie reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Tabula Rasa HealthCare earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Tabula Rasa HealthCare.

Who are some of Tabula Rasa HealthCare's key competitors?

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Adobe (ADBE), Micron Technology (MU), Canopy Growth (CGC), Netflix (NFLX), Advanced Micro Devices (AMD), GW Pharmaceuticals PLC- (GWPH), salesforce.com (CRM), VMware (VMW) and Align Technology (ALGN).

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 69)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 50)
  • Mr. Brian W. Adams, CFO & Sec. (Age 37)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (12.46%), Price T Rowe Associates Inc. MD (5.95%), Vanguard Group Inc. (4.95%), Jennison Associates LLC (4.18%), Jennison Associates LLC (4.18%) and NN Investment Partners Holdings N.V. (3.00%). Company insiders that own Tabula Rasa HealthCare stock include Andrea Carolan Speers, Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate, Orsula V Knowlton and Samira Beckwith. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which institutional investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Allianz Asset Management GmbH, Invesco Ltd., Waddell & Reed Financial Inc., BNP Paribas Arbitrage SA, AQR Capital Management LLC, Vanguard Group Inc. and Artemis Investment Management LLP. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Gordon Tunstall, Orsula V Knowlton and Samira Beckwith. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which institutional investors are buying Tabula Rasa HealthCare stock?

TRHC stock was bought by a variety of institutional investors in the last quarter, including First Trust Advisors LP, Janus Henderson Group PLC, Janus Henderson Group PLC, Intrinsic Edge Capital Management LLC, Brown Advisory Inc., Price T Rowe Associates Inc. MD, Rice Hall James & Associates LLC and Handelsbanken Fonder AB. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $56.99.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.26 billion and generates $204.27 million in revenue each year. The company earns $-47,270,000.00 in net income (profit) each year or $0.34 on an earnings per share basis. Tabula Rasa HealthCare employs 952 workers across the globe.View Additional Information About Tabula Rasa HealthCare.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com/.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  261 (Vote Outperform)
Underperform Votes:  234 (Vote Underperform)
Total Votes:  495
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 9/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel